Economic Environment - The company reported a challenging economic environment with slow recovery in Hong Kong, leading to cautious consumer spending and reduced local consumption[10] - The overall economic conditions have pressured the retail and service sectors in Hong Kong, impacting the company's operations[10] - The medical skin care industry remains competitive, facing rising operational costs and suppressed local demand[10] Financial Performance - The group’s revenue for the year ended March 31, 2025, decreased by HKD 4.0 million or 8.2% to HKD 45.1 million from HKD 49.1 million for the year ended March 31, 2024[18] - The total sales revenue, including prepaid treatment plan receipts, recorded a slight decline of HKD 1.4 million or 2.9%, from HKD 50.9 million to HKD 49.5 million[18] - The group reported a loss attributable to equity holders of HKD 3.4 million for the year ended March 31, 2025, an increase of HKD 0.4 million or 10.8% compared to HKD 3.0 million for the year ended March 31, 2024[19] - Basic loss per share for the period was HKD 0.85, an increase of 10.4% from HKD 0.77 in the previous year[19] - Other income increased by HKD 0.8 million or 78.9% to HKD 1.8 million for the year ending March 31, 2025, primarily due to a reversal of provisions and increased bank interest income[22] Operational Strategies - Cost-saving measures and operational optimizations have been implemented to enhance long-term business sustainability and performance[10] - The group is actively exploring deeper market penetration and offering a wider range of services, particularly focusing on anti-aging and preventive care[15] - The group is implementing cost-saving measures and improving operational efficiency to address rising operational costs and intense industry competition[18] - The group plans to continue seeking strategic growth opportunities to strengthen its competitive advantage and create long-term value for shareholders[15] Technological Advancements - The company is focused on technological advancements, continuously introducing advanced solutions to improve service quality and competitiveness[11] - The introduction of the "Titan Lift" laser treatment technology, which utilizes three laser wavelengths, aims to enhance skin firmness and elasticity[16] - The group is assessing how to integrate artificial intelligence into its services for more precise and data-driven skincare solutions[15] Human Resources - The medical team consists of experienced professionals, with most doctors having nearly or over 20 years of clinical experience, reinforcing the company's reputation as a trusted provider[11] - Employee costs decreased by HKD 0.7 million or 3.0% to HKD 23.9 million for the year ending March 31, 2025, due to reduced bonuses and salaries[24] - The group employed 27 full-time and 16 part-time employees as of March 31, 2025, compared to 29 full-time and 14 part-time employees in 2024[51] Corporate Governance - The company has established a remuneration committee to review and recommend compensation policies for directors and senior management, considering company and individual performance[78] - The independent non-executive directors have confirmed their independence, and their re-election was approved at the 2024 annual general meeting[75] - The company has established three committees: the audit committee, the remuneration committee, and the nomination committee, to oversee specific aspects of the company's affairs[126] - The board consists of four executive directors and three independent non-executive directors as of March 31, 2025[108] Environmental, Social, and Governance (ESG) Initiatives - The company is committed to fulfilling its corporate social responsibility and being accountable to individuals, communities, and the environment[164] - The company’s environmental, social, and governance report covers its performance in these areas during the operational period from April 1, 2024, to March 31, 2025[160] - The company has established key performance indicators for measurable comparisons in its environmental and social performance[162] - Total greenhouse gas emissions for 2025 were 48,045 kg CO2 equivalent, a decrease of 5.1% from 50,636 kg in 2024[179] Risk Management - The group faces foreign currency risk primarily from purchases denominated in currencies other than its operating currency, mainly USD[49] - The group has not implemented any interest rate hedging policies but will monitor interest rate risks closely[50] - The company has established a shareholder communication policy to provide timely and comprehensive information to shareholders and investors, which is reviewed at least annually[147] Shareholder Information - The company has not proposed a final dividend for the year ending March 31, 2025, consistent with 2024[58] - The company aims to ensure that the new share option plan aligns with the long-term growth interests of the group[87] - The company has no knowledge of any direct or indirect competition from its directors or major shareholders as of March 31, 2025[81]
密迪斯肌(08307) - 2025 - 年度业绩